Psoriasis: talking points from recent clinical trials

Taylor and Francis Group, Expert Opinion on Investigational Drugs, 12(31), p. 1265-1267, 2022

Journal article published in 2022 by Andrea Chiricozzi

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by